Xtant Medical Holdings, Inc. last reported quarterly results on Aug 11, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $23.0 million (-35.0% year over year) and diluted EPS of -$0.07. It usually reports 41–43 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 9, 2026.
Results for Q3 FY2026, the quarter ending around Sep 30, 2026. Expected on a Monday. Based on last year's release for the same quarter on Nov 10, 2025. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 41–43 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 11, 2026
42 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
23
-35.0%
|
-9
-365.2%
|
-0.07
-450.0%
|
|
May 13, 2026
43 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
21
-36.5%
|
-3
-5425.9%
|
-0.02
|
|
Nov 10, 2025
41 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
33
+19.0%
|
1
+126.0%
|
0.01
+125.0%
|
|
Aug 12, 2025
43 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
35
+18.3%
|
4
+191.9%
|
0.02
+166.7%
|
|
Apr 16, 2025
16 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
33
+18.0%
|
0
+101.3%
|
0.00
+100.0%
|
|
Mar 6, 2025
65 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
32
+12.1%
|
-3
+26.4%
|
-0.02
+28.3%
|
|
Nov 12, 2024
43 days after quarter end
|
Q3 FY2024
ended Sep 30, 2024
|
28
+11.7%
|
-5
-154.4%
|
-0.04
-157.1%
|
|
Aug 8, 2024
39 days after quarter end
|
—
ended Jun 30, 2024
|
—
|
—
|
—
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- XTNT (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Belgrade, MT
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1453593
- Former names
- Bacterin International Holdings, Inc. (until Aug 3, 2015); K KITZ INC (until May 21, 2010)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.